Hello. I’m Dr. Jinhag Baik, an ophthalmologist and head director of nuneHIM Eye Center on Siheung-daero in Guro-gu, Seoul.

When parents of young children ask me about orthokeratology (ortho-k, the overnight lenses often called “dream lenses” in Korea), the first question is usually not about results. It is about age: “My child is only in first grade. Isn’t that too young?” Close behind come “Is it too late at 11?” and “Can a child with astigmatism wear them?”

Short answer: the major ortho-k trials enrolled children from age 6, and slowing of eye growth tends to be larger when ortho-k starts at a younger age, roughly 6–8. But age is not the deciding factor on its own. Whether a child is a good candidate depends on how fast the myopia is progressing, the prescription and astigmatism, the shape and health of the cornea and tear film, and whether the family can keep up nightly lens care and regular check-ups.

Published November 11, 2026. Information is based on published studies and professional guidance available as of November 2026.

How does ortho-k work, and why does starting age come up?

Ortho-k lenses are rigid, highly oxygen-permeable lenses with a “reverse geometry” design. They are worn overnight to reshape the front of the cornea, which temporarily and reversibly reduces nearsightedness after the lenses come out (BCLA CLEAR report, 2021). Because the change is reversible, the cornea gradually returns to its original shape if wear stops.

In children, ortho-k is also used to slow myopia progression, which mostly means slowing the growth of the eye’s length (axial length). The 2025 Korean pediatric myopia consensus statement describes the main proposed mechanism as peripheral myopic defocus created by the reshaped cornea.

Starting age matters because younger eyes tend to grow faster, and axial growth does not reverse. Asking “what age?” is really asking “how fast is this child’s eye growing right now?”

For context, the same Korean consensus reports a myopia prevalence of 65.4% among Korean children and adolescents aged 5–18, with 6.9% highly myopic and about 20% high myopia at age 18.

What is the youngest age for ortho-k?

The key randomized trial (ROMIO) enrolled children aged 6–10, and the toric ortho-k study (TO-SEE) enrolled children aged 6–12. The Korean consensus key points state that ortho-k can be used from a young age because greater efficacy has been reported in younger children.

Evidence for children younger than 6 is limited in the studies I reviewed for this article, so I would not describe a lower age limit with confidence.

In practice, the bigger questions are practical ones. The 2024 Singapore Optometric Association (SOA) ortho-k guideline lists, among its candidate criteria, that the patient or a parent takes responsibility for lens care and insertion/removal, that the child regularly sleeps at least 8 hours, and that the family commits to check-ups at least every 3 months. The child also needs to tolerate lens handling and routine eye examinations.

Is ortho-k really more effective when started young?

Several studies point in that direction, although most were done in East Asian (mainly Hong Kong and mainland Chinese) children.

ROMIO randomized trial (Cho & Cheung, 2012). 102 children aged 6–10 with myopia of 0.50–4.00 D and astigmatism up to 1.25 D were randomized to ortho-k or single-vision glasses for 2 years; 78 completed (37 and 41).

Outcome Ortho-k Glasses
2-year axial elongation 0.36 mm 0.63 mm
Fast progression (>1.00 D/year), age 7–8 20% 65%
Fast progression (>1.00 D/year), age 9–10 9% 13%

Axial elongation was 43% slower with ortho-k on average. It correlated with the child’s starting age, not with the starting prescription. Five children stopped ortho-k because of adverse events.

What this does not mean: 43% slower growth is not “43% less myopia” or a cure. The eyes in the ortho-k group still grew.

ROMIO and TO-SEE reanalysis (Cho & Cheung, 2017). Pooling 136 children, the authors defined rapid progression as axial growth above 0.36 mm per year. In 6–8-year-olds, ortho-k reduced the risk of rapid progression by 88.8%, with a 2-year number needed to treat of 1.8. In 9–12-year-olds the number needed to treat was 11.8 and not statistically significant (P = 0.197).

What this does not mean: it does not show ortho-k fails in older children. Fewer older children progressed rapidly to begin with, which makes a difference harder to prove in a small sample.

American Academy of Ophthalmology assessment (VanderVeen et al., 2019). Reviewing 13 studies, AAO concluded that ortho-k typically reduced axial elongation by about 50% over 2 years (about 0.3 mm versus 0.6 mm, roughly 0.5 D). Effects may be greater in younger children and in those with larger-than-average pupils, potentially more so when started at 6–8. AAO also stressed that safety remains a concern because of the risk of potentially blinding microbial keratitis.

A 2023 Cochrane living review (64 randomized trials, 11,617 children aged 4–18) found ortho-k reduced axial elongation by about 0.19 mm at one year and 0.28 mm at two years compared with controls, with evidence certainty ranging from very low to moderate.

Is it too late to start at 10, 12 or older?

Not necessarily. A 2025 retrospective study from Tianjin (Hu et al., 1,303 children aged 7–16) grouped children by age (11) and myopia (−3.00 D), adjusting for physiological eye growth. The “excellent response” rate in year one was 85.95% in older children with higher myopia and 13.21% in younger children with lower myopia. The authors suggested younger children with low myopia may need additional therapy.

What this does not mean: “excellent response” was the authors’ own threshold, and younger eyes grow faster, so they reach it less easily. It does not mean ortho-k is useless in young children, and a retrospective design has limits.

A 10-year Japanese study (Hiraoka et al., 2018; 53 ortho-k and 39 soft-lens wearers) found less myopia progression with ortho-k (−1.26 D vs −1.79 D) at all starting ages except 16, with no significant difference in the number of adverse events.

For teenagers, the Korean consensus notes that myopia stabilized around age 15 on average in the COMET and DREAM studies, with a median yearly increase of 0.19 D at ages 13–15 and 0.09 D at 16–18, although some people progress into their 20s. If a teenager’s myopia has almost stopped, the goal shifts from myopia control toward daytime vision, so it helps to be clear about what you are hoping for.

What prescription range suits ortho-k?

The Korean consensus states that the most successful and predictable results are seen between −0.5 and −4.0 D. For higher myopia, efficacy has been observed with partial-correction ortho-k plus daytime glasses.

In the HM-PRO trial (Charm & Cho, 2013), children aged 8–11 with myopia of −5.00 D or more had 4.00 D corrected by ortho-k and the rest by glasses. Axial growth over 2 years was 0.19 mm versus 0.51 mm with glasses alone (63% slower). Only 28 of 52 children completed the study, and this approach still requires daytime glasses.

Can children with astigmatism wear ortho-k?

Often, yes. Per the Korean consensus, most manufacturers and practitioners recommend ortho-k for astigmatism up to −1.75 D, and a protective effect has been reported up to −3.5 D.

In TO-SEE (Chen, Cheung & Cho, 2013), 80 children aged 6–12 with 0.50–5.00 D of myopia and 1.25–3.50 D of with-the-rule astigmatism were followed for 2 years (nonrandomized). Axial growth was 0.31 mm with toric ortho-k versus 0.64 mm with glasses, 52% slower; 58 children completed the study.

One practical check: ortho-k reshapes the corneal surface. If total astigmatism in the glasses prescription differs substantially from corneal astigmatism, some astigmatism may remain after treatment, so this is checked with corneal topography before fitting.

Which eye conditions rule ortho-k out?

The SOA guideline lists the following as candidate criteria and contraindications. It is a professional guideline from Singapore, not a Korean standard, but it is a clear checklist.

Good candidate signsAvoid or use caution
Prescription within the lens manufacturer’s indicated rangeKeratoconus, central corneal scarring, corneal dystrophy
Symmetric corneal curvature within normal topographer rangePersistent corneal staining above grade 2, pannus
Tear break-up time of 10 seconds or more; dry eye or MGD managed firstLid or eyelash abnormalities, ptosis
Regular sleep of at least 8 hoursPrior uveitis, allergic conjunctivitis above grade 2
Follow-up at least every 3 monthsSevere dry eye; retinal disease, lens opacity, glaucoma

Start now or wait? How progression speed guides the decision

The Korean consensus lists factors that point to a higher risk of progression: younger age at myopia onset, myopia of −3.00 D or more at presentation, progression of 0.50 D or more per year, axial growth of 0.3–0.4 mm or more per year, parental (especially high) myopia, East Asian ethnicity, less than 2 hours outdoors a day, and near work closer than 30 cm or longer than 45 minutes at a stretch.

These factors identify children for whom myopia control should be discussed. They do not mean “choose ortho-k”. The consensus cites a 2023 network meta-analysis finding ortho-k’s effect comparable to atropine eye drops and daytime myopia-control soft lenses, and it notes that myopia-control spectacle lenses are easier to use with few long-term side effects.

After starting, the SOA guideline treats axial growth of 0.1 mm or more, or a myopic shift above 0.50 D, within 6 months as an inadequate response. The Korean consensus suggests changing lens design or adding low-dose atropine eye drops if progression stays rapid.

What about daytime vision and safety?

Daytime vision can fade slightly toward evening if overnight wear is too short or myopia is high. The SOA guideline uses good vision more than 6 hours after lens removal as one marker of a satisfactory review.

The most important risk is microbial keratitis. In a US study (Bullimore et al., 2013), the estimated rate in children was 13.9 per 10,000 patient-years (95% CI 1.7–50.4), a wide range that should be read as an order of magnitude. The Korean consensus describes the risk as similar to extended-wear soft lenses.

Basic habits from the US CDC: keep lenses and cases away from all water, store lenses in fresh solution (never water), wash and dry hands before handling, replace the case at least every 3 months, and remove lenses and contact your eye doctor if your child’s eye is uncomfortable. The SOA guideline adds skipping wear when the child is unwell or the eye is inflamed, and during flights or wherever hygiene is hard to maintain.

What tests are done before starting?

  • Visual acuity and refraction, with cycloplegic refraction when indicated
  • Axial length measurement as a baseline for tracking progression
  • Corneal topography (curvature, corneal astigmatism, symmetry)
  • Slit-lamp examination of the cornea, conjunctiva and lids
  • Tear film assessment
  • Pupil size
  • Retinal (fundus) examination

After the first lenses, the SOA guideline suggests reviews after the first night, at 1 week and around 4 weeks, then every 3 months, including axial length.

Practical tips for busy families

  • Decide who handles the nightly lens insertion and morning cleaning, with a backup person for late-work weeks.
  • Protect sleep: at least 8 hours is the guideline benchmark.
  • If a lens feels stuck in the morning, don’t force it; follow the removal steps you were taught.
  • Starting during a school break makes the frequent early check-ups easier.
  • Keep copies of axial length results so you can compare year to year.
  • Keep outdoor time and good near-work habits. The Korean consensus says these may reduce the risk of myopia onset, though their effect on existing progression is debated.

FAQ

What is the youngest age for ortho-k? Key trials enrolled children from age 6. Whether a child is ready also depends on lens handling and family supervision.

Should every young child start as early as possible? Not necessarily. Effects tend to be larger in younger children, but a child with very low, slow-moving myopia may simply be monitored first.

Is ortho-k better than atropine or myopia-control glasses? Not necessarily. The Korean consensus cites evidence that its effect is comparable to atropine and daytime myopia-control soft lenses, and myopia-control glasses are easier to use.

My child has −5 D of myopia. Is ortho-k possible? Partial-correction ortho-k with daytime glasses has been studied, with slower eye growth, but in a small trial and with glasses still needed during the day.

Can a child with 2 D of astigmatism wear it? Often, with toric designs, after confirming corneal and total astigmatism match.

Who should avoid ortho-k? Children with keratoconus, corneal scarring or dystrophy, persistent corneal damage, severe dry eye or active inflammation, or families unable to keep up hygiene and follow-up.

Will ortho-k stop myopia? No. It slows eye growth on average; eyes still grow, so axial length is monitored.

When can we tell if it is working? Daytime vision changes quickly, but myopia control is judged by axial length over months to a year.

Where is nuneHIM Eye Center? 551 Siheung-daero, Gwanghui Building 5F, Guro-gu, Seoul, about a 3-minute walk from Guro Digital Complex Station (Line 2) and close to the Gasan Digital Complex area. More information: https://nunehim.com

“The right time to start ortho-k is set not by a child’s age, but by how fast the eye is growing and the safety habits the family can keep.”

This article is educational and based on published studies and professional guidance as of November 2026. It does not promote a specific product, results vary between individuals, and it does not replace an individual eye examination.

References

  1. Lee YH, et al. Myopia management consensus statement in South Korean children 2025. Korean J Ophthalmol. 2026;40(2):185–205. https://pubmed.ncbi.nlm.nih.gov/41633654/ — https://doi.org/10.3341/kjo.2025.0179
  2. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–7085. https://pubmed.ncbi.nlm.nih.gov/22969068/ — https://doi.org/10.1167/iovs.12-10565
  3. Cho P, Cheung SW. Protective role of orthokeratology in reducing risk of rapid axial elongation: a reanalysis of data from the ROMIO and TO-SEE studies. Invest Ophthalmol Vis Sci. 2017;58(3):1411–1416. https://pubmed.ncbi.nlm.nih.gov/28253404/ — https://doi.org/10.1167/iovs.16-20594
  4. VanderVeen DK, et al. Use of orthokeratology for the prevention of myopic progression in children: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(4):623–636. https://pubmed.ncbi.nlm.nih.gov/30476518/ — https://doi.org/10.1016/j.ophtha.2018.11.026
  5. Lawrenson JG, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;2:CD014758. https://pubmed.ncbi.nlm.nih.gov/36809645/ — https://doi.org/10.1002/14651858.CD014758.pub2
  6. Hu X, et al. Orthokeratology for myopia control: a three-year longitudinal study on axial length modulation influenced by baseline age and spherical equivalent. BMC Ophthalmol. 2025;25(1):466. https://pubmed.ncbi.nlm.nih.gov/40826321/ — https://doi.org/10.1186/s12886-025-04303-5
  7. Hiraoka T, et al. Safety and efficacy following 10-years of overnight orthokeratology for myopia control. Ophthalmic Physiol Opt. 2018;38(3):281–289. https://pubmed.ncbi.nlm.nih.gov/29691927/ — https://doi.org/10.1111/opo.12460
  8. Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013;90(6):530–539. https://pubmed.ncbi.nlm.nih.gov/23645372/ — https://doi.org/10.1097/OPX.0b013e318293657d
  9. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013;54(10):6510–6517. https://pubmed.ncbi.nlm.nih.gov/24003088/ — https://doi.org/10.1167/iovs.13-12527
  10. Singapore Optometric Association. Orthokeratology Fitting and Myopia Management Guideline, Ver 1.0 (3 March 2024). https://singaporeoptometricassociation.com/wp-content/uploads/2024/05/SOA-Orthokeratology-Fitting-and-Management-Guideline-2024.pdf
  11. Bullimore MA, Sinnott LT, Jones-Jordan LA. The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci. 2013;90(9):937–944. https://pubmed.ncbi.nlm.nih.gov/23892491/ — https://doi.org/10.1097/OPX.0b013e31829cac92
  12. Vincent SJ, et al. CLEAR – Orthokeratology. Cont Lens Anterior Eye. 2021;44(2):240–269. https://pubmed.ncbi.nlm.nih.gov/33775379/ — https://doi.org/10.1016/j.clae.2021.02.003
  13. Centers for Disease Control and Prevention. Preventing Eye Infections When Wearing Contacts (May 27, 2025). https://www.cdc.gov/contact-lenses/prevention/index.html

Related reading on this site: When Can a Child Stop Ortho-K? · Ortho-K Lenses and Eye Infections in Seoul · Myopia Control Children Seoul: OK Lens vs Atropine

2 responses to “How Young Is Too Young for Ortho-K? When a Child Can Start, and the Prescription and Cornea Criteria That Matter”

Leave a Reply